Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2020-05-28
2021-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tap Block and Cesarean Delivery: Efficacy and Consumption of Postoperative Drugs
NCT02801968
The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section (CS)
NCT02053922
Transverse Abdominal Block for Analgesia in Casarean Section
NCT02122510
Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia
NCT05785377
Median and Paramedian Anesthesia in Cesarean Section
NCT04617249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
giving tab block
giving patients tab block
tab block
injection of tab block to women who are doing cs
women who will not receive tab block or PCA
no tab block or PCA will be given
giving PCA
Giving PCA to patients
PCA
giving women PCA
women who will not receive tab block or PCA
no tab block or PCA will be given
Patients who will not receive PCA or tab block
No tab block or PCA
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tab block
injection of tab block to women who are doing cs
PCA
giving women PCA
women who will not receive tab block or PCA
no tab block or PCA will be given
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
42 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aljazeera Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahmoud Alalfy, PhD
Role: STUDY_CHAIR
Algezeera hospitaland National Research Centre ,Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aljazeera( Al Gazeera) hospital
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
tab block
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.